Healthcare / Medical Care FacilitiesThailand
$4.26
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-170.3M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.4B
P/E
17.0x
↓EV/EBITDA
9.3x
↓ROE
5.4%
↑Gross Margin
50.2%
↑Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-17.9%
FCF CAGR
—
FCF margin
-38.1%
FCF / Net income
-2.06x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $471.7M · net income $87.2M · FCF $-179.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $471.7M | $471.7M | $533.7M | $707.8M | $853.6M |
| Net Income | $87.2M | $87.2M | $139.4M | $192.6M | $270.3M |
| EBITDA | $129.4M | $129.4M | $185.4M | $260.9M | $355.8M |
| EPS | — | — | 0.40 | 0.69 | 0.77 |
| Gross Margin | 50.2% | 50.2% | 52.7% | 54.9% | 55.4% |
| Operating Margin | 23.1% | 23.1% | 31.8% | 34.7% | 40.1% |
| Net Margin | 18.5% | 18.5% | 26.1% | 27.2% | 31.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.01 | 0.23 |
| Current Ratio | 7.91 | 7.91 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-179.5M | $-179.5M | $-170.3M | $104.9M | $-13.2M |
| Returns | |||||
| ROE | 5.4% | 5.4% | 8.1% | 11.4% | 47.5% |
| Valuation | |||||
| P/E | 17.04 | 17.04 | 22.00 | 25.51 | — |
| EV/EBITDA | 9.26 | 9.26 | 14.43 | 17.89 | — |
| P/B | 0.87 | 0.87 | 1.79 | 2.91 | — |
| Growth & Yield | |||||
| Revenue Growth | -11.6% | -11.6% | -24.6% | -17.1% | — |
| EPS Growth | — | — | -42.0% | -10.6% | — |
| Dividend Yield | 5.9% | 5.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-21.3%
Start / end P/E
n/dx → n/dx
EPS bridge
0.40 → n/d
Residual
-27.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.